Mediclinic International Plc

Public consensus   -   Last updated 08/10/20

Reporting currency: GBP
Reporting unit: Absolute
 
NO. OF
FORECASTS
FY21
CONSENSUS
08/10/20
FY21
MIN
FY21
MAX
Hirslanden (CHF'm) - Adjusted
Revenue
7
1,769
1,675
1,826
EBITDA
7
269
254
288
EBITDA margin (%)
7
15.2
14.3
16.4
Average FX rate GBP/CHF
7
1.21
1.18
1.25
Southern Africa (ZAR'm) - Adjusted
Revenue
7
15,758
14,854
16,721
EBITDA
7
2,455
1,912
2,945
EBITDA margin (%)
7
15.5
12.9
17.6
Average FX rate GBP/ZAR
7
21.57
21.00
22.00
Middle East (AED'm) - Adjusted
Revenue
7
3,379
3,152
3,522
EBITDA
7
446
332
491
EBITDA margin (%)
7
13.2
10.0
14.7
Average FX rate GBP/AED
7
4.68
4.59
4.75
Adjusted Group (GBP'm)
Revenue
7
2,912
2,780
3,037
EBITDA
7
430
387
461
EBITDA margin (%)
7
14.8
13.9
15.5
Operating profit
7
211
175
247
Earnings per share (pence)
7
12.3
9.6
16.2
Dividend per share (pence)
5
1.6
-
3.2
Net Debt
6
2,095
1,635
2,251
Net cash generated from operating activities
6
303
249
358
Total Group Capex
7
195
155
249

Disclaimer

Mediclinic International plc (“Mediclinic”) does not endorse or adopt any of the consensus estimates expressed in this report. The report represents the views of analysts from which the consensus estimates are derived. Mediclinic will not provide any commentary on the consensus or answer questions on it. The circulation of the consensus by Mediclinic is not mandatory and Mediclinic may amend its practice on this at any time.